Csenge Advisory Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.33M Sell
3,471
-26
-0.7% -$9.98K 0.07% 217
2025
Q1
$1.48M Buy
3,497
+87
+3% +$36.9K 0.08% 189
2024
Q4
$1.26M Sell
3,410
-1,250
-27% -$461K 0.07% 221
2024
Q3
$2.34M Buy
4,660
+592
+15% +$297K 0.12% 137
2024
Q2
$2.2M Buy
4,068
+77
+2% +$41.7K 0.13% 126
2024
Q1
$2.07M Sell
3,991
-51
-1% -$26.4K 0.12% 140
2023
Q4
$1.91M Sell
4,042
-155
-4% -$73.1K 0.12% 151
2023
Q3
$1.83M Buy
4,197
+238
+6% +$104K 0.12% 140
2023
Q2
$1.76M Sell
3,959
-154
-4% -$68.4K 0.12% 143
2023
Q1
$1.89M Buy
4,113
+77
+2% +$35.4K 0.14% 133
2022
Q4
$2.07M Sell
4,036
-135
-3% -$69.3K 0.16% 119
2022
Q3
$1.9M Sell
4,171
-231
-5% -$105K 0.16% 123
2022
Q2
$2.12M Buy
4,402
+534
+14% +$258K 0.18% 109
2022
Q1
$1.9M Buy
3,868
+591
+18% +$290K 0.15% 123
2021
Q4
$1.26M Sell
3,277
-24
-0.7% -$9.21K 0.11% 156
2021
Q3
$1.24M Buy
3,301
+24
+0.7% +$9.02K 0.1% 176
2021
Q2
$1.26M Buy
3,277
+2,588
+376% +$994K 0.11% 156
2021
Q1
$249K Sell
689
-247
-26% -$89.3K 0.03% 427
2020
Q4
$301K Sell
936
-17
-2% -$5.47K 0.04% 321
2020
Q3
$270K Sell
953
-1,120
-54% -$317K 0.04% 313
2020
Q2
$545K Sell
2,073
-140
-6% -$36.8K 0.08% 177
2020
Q1
$502K Buy
2,213
+872
+65% +$198K 0.13% 142
2019
Q4
$405K Buy
1,341
+383
+40% +$116K 0.1% 185
2019
Q3
$230K Buy
+958
New +$230K 0.06% 234
2018
Q4
Sell
-53
Closed -$14K 555
2018
Q3
$14K Buy
+53
New +$14K 0.01% 436